IL6 and systemic sclerosis: Increased levels of IL-6, which can be found in the sera and skin of SSc patients, correlate with disease severity, in particular with the extent of skin and pulmonary involvement, and they can also predict SSc-linked interstitial lung disease (ILD), decline and mortality [11].